Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Suzhou Kintor Pharmaceuticals Inc. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners but are both located within 1 distinct art unit. This suggests that while different individuals are reviewing the applications, the subject matter remains concentrated within a single specialized group. The focus within 1 distinct art unit indicates a consistent technical classification for the company's current active filings.
TOWNSLEY, SARA ELIZABETH is the busiest examiner for the company, handling 1 busiest examiner pending office action. With 2 pending office actions total and 2 distinct examiners involved, the prosecution workload is distributed equally. Each of the 2 distinct examiners handles 1 busiest examiner pending office action. This arrangement requires the company to manage 2 separate examiner relationships within the same art unit, introducing different individual perspectives into the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TOWNSLEY, SARA ELIZABETH | 1 | 25.5% | +49.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723083 | MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON | TOWNSLEY, SARA ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723083 | MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON | TOWNSLEY, SARA ELIZABETH | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723083 | MULTI-PROTEIN DEGRADATION AGENT HAVING IMIDE SKELETON | TOWNSLEY, SARA ELIZABETH | — | §102§103§112DP | Non-Final OA | — | Pending | Jun 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial